Instruments for Upper Tract Biopsy and Treatment
From the introduction of endoscopic approaches to genitourinary disease at the beginning of the nineteenth century to advances in 1970s that ushered in the current era of Endourology, the field has undergone continuous growth based on improved visualization, advances in scope design and instrument innovation. Currently available techniques offer access to the entire urinary tract via a retrograde ureteral or antegrade percutaneous approach for the inspection, biopsy, and treatment of the spectrum of benign and malignant pathology. While urine studies and cross-sectional imaging are utilized in the initial evaluation, direct visual inspection, and biopsy is required for the assessment of any abnormal findings. The current generation of digital flexible ureteroscopes are lighter and less cumbersome than their predecessors with better image quality. Instruments including forceps, baskets, and resection loops are available to maximize the diagnostic yield of endoscopic biopsy. Despite progress, it is critical to recognize that undergrading and understaging remain a significant concern even for experienced practitioners. This can best be tempered with a comprehensive evaluation of the entire urothelium, systematic approach to specimen collection and close clinical follow-up. In this chapter, we review basic endoscopic techniques for the biopsy of upper urinary tract lesions.
KeywordsUrothelial carcinoma Upper tract Ureteroscopy Endoscopic biopsy Diagnosis Pyelography
Author acknowledges the contribution of Denton Allman, MD and Jonathan Wagmaister, MD, Westchester Medical Health Network, New York Medical College, Valhalla, NY and thanks him for his helpful comments and feedback.
This video clip shows endoscopy, biopsy followed by laser ablation of the base of tumor (MP4 117679 kb)
This clip shows a small renal lesion biopsy and ablation (MP4 116912 kb)
- 1.Transitional cell cancer of the renal pelvis and ureter treatment—for health professionals (PDQ) Bethesda (MD): National Cancer Institute; 2015. Available at: http://www.cancer.gov/types/kidney/hp/transitional-cell-treatment-pdq. Accessed 12 Oct 2015.
- 5.Davis R, Jones JS, Barocas DA, Castle EP, Lang EK, Leveillee RJ, Messing EM, Miller SD, Peterson AC, Turk TMT, Weitzel W. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. Linthicum (MD): American Urological Association; 2012. Available at: https://www.auanet.org/education/guidelines/asymptomatic-microhematuria.cfm. Accessed 15 Oct 2015.CrossRefPubMedGoogle Scholar
- 6.Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, et al. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy. BJU Int. 2012;110(2 Pt 2):E7–13.CrossRefPubMedGoogle Scholar
- 10.Nieder AM, Manoharan M. The role of the surgeon and transurethral resection in the treatment of superficial bladder cancer. SciWorld J. 2006;7(6):2626–31.Google Scholar
- 14.Bird V. Flexible ureteroscopes: fiberoptic and digital. In: Monga M, editor. Ureteroscopy. Indications, instrumentation and technique. New York: Humana Press; 2013. p. 111.Google Scholar
- 22.Cohen JH, Cohen SD, Grasso M. Flexible ureteroscopy: wireless and sheathless. In: Monga M, editor. Ureteroscopy. Indications, instrumentation and technique. New York: Humana Press; 2013. p. 297.Google Scholar